
FDA Approves Merck’s ENFLONSIA™ to Prevent RSV in Infants
FDA Approves Merck’s ENFLONSIA™ to Protect Infants from Severe RSV Illness Merck operating as MSD outside the United States and Canada, has received a significant regulatory milestone with the U.S.…












